Dr. Jay Lalezari

Dr. Jay Lalezari, a physician and researcher with decades of experience in virology and the CEO of CytoDyn, discusses groundbreaking advancements in treating triple-negative breast cancer with leronlimab. He details how this monoclonal antibody can transform cold tumors into hot ones, enhancing the efficacy of immunotherapy. Jay shares impressive survival data, including a cohort of patients with significant long-term remission. He also explores potential applications in colorectal cancer and the interest of major pharmaceutical companies in these innovative treatments.